Table 3. 12-month prevalence of (comorbid) common mental disorders (n = 6,506).
Any mood disorder | Any anxiety disorder | Any substance use disorder | ||||
---|---|---|---|---|---|---|
% | OR (95% CI) | % | OR (95% CI) | % | OR (95% CI) | |
NONE | 5.1 | 1 | 8.2 | 1 | 5.9 | 1 |
PHYonly | 7.4 | 1.59 (1.17,2.15) | 13.3 | 1.80 (1.44,2.26) | 4.6 | 1.19 (0.78,1.82)* |
MUSonly | 13.5 | 2.58 (1.56,4.27) | 19.0 | 2.34 (1.41,3.87) | 7.1 | 1.66 (0.67,4.09) |
MUS+PHY | 10.9 | 2.13 (1.25,3.63) | 17.4 | 2.19 (1.46,3.29) | 8.4 | 3.43 (1.85,6.36)* |
The analyses were adjusted for sex, age, partner status, employment situation and level of education.
NONE: No explained physical symptoms, no MUS
PHYonly: explained physical symptoms, no MUS
MUSonly: MUS, no explained physical symptoms
MUS+PHY: both MUS and explained physical symptoms
Percentages: weighted data
OR: odds ratio
95% CI: 95% confidence interval
* When PHYonly, MUSonly and MUS+PHY were respectively used as the reference group, the only significant difference was found between PHYonly and MUS+PHY for any substance use disorder.